Pawel Widomski

Pawel Widomski is a seasoned professional in regulatory affairs with extensive experience in the biopharmaceutical industry, currently serving as Senior Director of Global Regulatory Affairs CMC at BioNTech SE since February 2022. Prior roles include Director at BioNTech SE, Associate Director, Senior Manager, and Manager at the Healthcare Business of Merck from January 2017 to February 2022, and consultancy as Owner from November 2014 to December 2016. Prior to that, Pawel held positions at Accupharma, Health-Med, SciencePharma, and the Institute of Physical Chemistry of the Polish Academy of Sciences, focusing on CMC documentation, regulatory compliance, and analytical method development. Academic credentials include a Master's degree in Pharmacy from Akademia Medyczna w Warszawie, completed in 2007.